nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC22A5—Dactinomycin—muscle cancer	0.672	1	CbGbCtD
Cefepime—Consciousness abnormal—Vincristine—muscle cancer	0.018	0.0549	CcSEcCtD
Cefepime—Septicemia—Etoposide—muscle cancer	0.0112	0.034	CcSEcCtD
Cefepime—Neurotoxicity—Vincristine—muscle cancer	0.00807	0.0246	CcSEcCtD
Cefepime—Altered state of consciousness—Vincristine—muscle cancer	0.00678	0.0206	CcSEcCtD
Cefepime—Septicemia—Methotrexate—muscle cancer	0.00669	0.0204	CcSEcCtD
Cefepime—Neurotoxicity—Etoposide—muscle cancer	0.00654	0.0199	CcSEcCtD
Cefepime—Septicemia—Doxorubicin—muscle cancer	0.00579	0.0176	CcSEcCtD
Cefepime—Myoclonus—Vincristine—muscle cancer	0.0052	0.0158	CcSEcCtD
Cefepime—Nephropathy toxic—Etoposide—muscle cancer	0.00441	0.0134	CcSEcCtD
Cefepime—Extravasation—Dactinomycin—muscle cancer	0.00401	0.0122	CcSEcCtD
Cefepime—Injection site inflammation—Doxorubicin—muscle cancer	0.00394	0.012	CcSEcCtD
Cefepime—Neurotoxicity—Methotrexate—muscle cancer	0.00391	0.0119	CcSEcCtD
Cefepime—Hypocalcaemia—Dactinomycin—muscle cancer	0.00382	0.0116	CcSEcCtD
Cefepime—Extravasation—Vincristine—muscle cancer	0.00359	0.0109	CcSEcCtD
Cefepime—Neurotoxicity—Doxorubicin—muscle cancer	0.00339	0.0103	CcSEcCtD
Cefepime—Aplastic anaemia—Dactinomycin—muscle cancer	0.00329	0.01	CcSEcCtD
Cefepime—Prothrombin level increased—Doxorubicin—muscle cancer	0.0032	0.00975	CcSEcCtD
Cefepime—Sepsis—Dactinomycin—muscle cancer	0.00304	0.00925	CcSEcCtD
Cefepime—Phlebitis—Dactinomycin—muscle cancer	0.00295	0.00898	CcSEcCtD
Cefepime—Extravasation—Etoposide—muscle cancer	0.0029	0.00884	CcSEcCtD
Cefepime—Coma—Vincristine—muscle cancer	0.00286	0.0087	CcSEcCtD
Cefepime—Hepatic failure—Dactinomycin—muscle cancer	0.00283	0.00861	CcSEcCtD
Cefepime—Inflammation—Etoposide—muscle cancer	0.00261	0.00795	CcSEcCtD
Cefepime—Vaginal moniliasis—Doxorubicin—muscle cancer	0.0026	0.00793	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Etoposide—muscle cancer	0.00253	0.00771	CcSEcCtD
Cefepime—Hepatic failure—Vincristine—muscle cancer	0.00253	0.00769	CcSEcCtD
Cefepime—Vulvovaginal candidiasis—Doxorubicin—muscle cancer	0.0025	0.00761	CcSEcCtD
Cefepime—Candida infection—Etoposide—muscle cancer	0.00242	0.00736	CcSEcCtD
Cefepime—Vulvovaginal mycotic infection—Doxorubicin—muscle cancer	0.0024	0.00732	CcSEcCtD
Cefepime—Local reaction—Doxorubicin—muscle cancer	0.00237	0.00723	CcSEcCtD
Cefepime—Encephalopathy—Methotrexate—muscle cancer	0.00236	0.0072	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00229	0.00697	CcSEcCtD
Cefepime—Liver disorder—Methotrexate—muscle cancer	0.00223	0.00678	CcSEcCtD
Cefepime—Sepsis—Etoposide—muscle cancer	0.0022	0.00669	CcSEcCtD
Cefepime—Phlebitis—Etoposide—muscle cancer	0.00214	0.0065	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.00211	0.00644	CcSEcCtD
Cefepime—Pancytopenia—Dactinomycin—muscle cancer	0.00209	0.00635	CcSEcCtD
Cefepime—Oral candidiasis—Doxorubicin—muscle cancer	0.00207	0.0063	CcSEcCtD
Cefepime—Neutropenia—Dactinomycin—muscle cancer	0.00205	0.00625	CcSEcCtD
Cefepime—Stupor—Methotrexate—muscle cancer	0.00203	0.00619	CcSEcCtD
Cefepime—Pneumonia—Dactinomycin—muscle cancer	0.00197	0.006	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00194	0.00591	CcSEcCtD
Cefepime—Hypercalcaemia—Doxorubicin—muscle cancer	0.00189	0.00576	CcSEcCtD
Cefepime—Pancytopenia—Vincristine—muscle cancer	0.00186	0.00567	CcSEcCtD
Cefepime—Neutropenia—Vincristine—muscle cancer	0.00184	0.00559	CcSEcCtD
Cefepime—Agranulocytosis—Dactinomycin—muscle cancer	0.00183	0.00556	CcSEcCtD
Cefepime—Pneumonia—Vincristine—muscle cancer	0.00176	0.00536	CcSEcCtD
Cefepime—Extravasation—Methotrexate—muscle cancer	0.00174	0.0053	CcSEcCtD
Cefepime—Erythema multiforme—Dactinomycin—muscle cancer	0.00166	0.00506	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00166	0.00504	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00162	0.00494	CcSEcCtD
Cefepime—Chills—Dactinomycin—muscle cancer	0.00158	0.0048	CcSEcCtD
Cefepime—Inflammation—Methotrexate—muscle cancer	0.00156	0.00476	CcSEcCtD
Cefepime—Hallucination—Vincristine—muscle cancer	0.00156	0.00476	CcSEcCtD
Cefepime—Erythema—Dactinomycin—muscle cancer	0.00153	0.00466	CcSEcCtD
Cefepime—Vaginal inflammation—Methotrexate—muscle cancer	0.00152	0.00462	CcSEcCtD
Cefepime—Pancytopenia—Etoposide—muscle cancer	0.00151	0.0046	CcSEcCtD
Cefepime—Extravasation—Doxorubicin—muscle cancer	0.00151	0.00459	CcSEcCtD
Cefepime—Vasodilation—Doxorubicin—muscle cancer	0.0015	0.00455	CcSEcCtD
Cefepime—Vasodilation procedure—Doxorubicin—muscle cancer	0.0015	0.00455	CcSEcCtD
Cefepime—Neutropenia—Etoposide—muscle cancer	0.00149	0.00453	CcSEcCtD
Cefepime—Depressed level of consciousness—Methotrexate—muscle cancer	0.00147	0.00446	CcSEcCtD
Cefepime—Hypocalcaemia—Doxorubicin—muscle cancer	0.00144	0.00437	CcSEcCtD
Cefepime—Vaginal infection—Methotrexate—muscle cancer	0.00143	0.00436	CcSEcCtD
Cefepime—Pneumonia—Etoposide—muscle cancer	0.00143	0.00434	CcSEcCtD
Cefepime—Aplastic anaemia—Methotrexate—muscle cancer	0.00143	0.00434	CcSEcCtD
Cefepime—Anaemia—Dactinomycin—muscle cancer	0.00141	0.00431	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00141	0.00428	CcSEcCtD
Cefepime—Renal failure—Etoposide—muscle cancer	0.00139	0.00424	CcSEcCtD
Cefepime—Coma—Methotrexate—muscle cancer	0.00139	0.00422	CcSEcCtD
Cefepime—Leukopenia—Dactinomycin—muscle cancer	0.00137	0.00417	CcSEcCtD
Cefepime—Inflammation—Doxorubicin—muscle cancer	0.00135	0.00412	CcSEcCtD
Cefepime—Agranulocytosis—Etoposide—muscle cancer	0.00132	0.00403	CcSEcCtD
Cefepime—Sepsis—Methotrexate—muscle cancer	0.00132	0.00401	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00131	0.004	CcSEcCtD
Cefepime—Vaginal inflammation—Doxorubicin—muscle cancer	0.00131	0.004	CcSEcCtD
Cefepime—Anaemia—Vincristine—muscle cancer	0.00126	0.00385	CcSEcCtD
Cefepime—Colitis—Doxorubicin—muscle cancer	0.00126	0.00384	CcSEcCtD
Cefepime—Agitation—Vincristine—muscle cancer	0.00126	0.00383	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—muscle cancer	0.00125	0.00382	CcSEcCtD
Cefepime—Infection—Dactinomycin—muscle cancer	0.00124	0.00378	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—muscle cancer	0.00124	0.00378	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—muscle cancer	0.00123	0.00376	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—muscle cancer	0.00123	0.00373	CcSEcCtD
Cefepime—Leukopenia—Vincristine—muscle cancer	0.00122	0.00373	CcSEcCtD
Cefepime—Thrombocytopenia—Dactinomycin—muscle cancer	0.00122	0.00372	CcSEcCtD
Cefepime—Erythema multiforme—Etoposide—muscle cancer	0.0012	0.00366	CcSEcCtD
Cefepime—Coma—Doxorubicin—muscle cancer	0.0012	0.00366	CcSEcCtD
Cefepime—Convulsion—Vincristine—muscle cancer	0.00118	0.00361	CcSEcCtD
Cefepime—Chills—Etoposide—muscle cancer	0.00114	0.00348	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—muscle cancer	0.00114	0.00347	CcSEcCtD
Cefepime—Anaphylactic shock—Vincristine—muscle cancer	0.00112	0.0034	CcSEcCtD
Cefepime—Infection—Vincristine—muscle cancer	0.00111	0.00338	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—muscle cancer	0.00111	0.00337	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.0011	0.00334	CcSEcCtD
Cefepime—Thrombocytopenia—Vincristine—muscle cancer	0.00109	0.00333	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00109	0.00332	CcSEcCtD
Cefepime—Dysgeusia—Etoposide—muscle cancer	0.00108	0.0033	CcSEcCtD
Cefepime—Pain—Dactinomycin—muscle cancer	0.00107	0.00325	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—muscle cancer	0.00106	0.00323	CcSEcCtD
Cefepime—Feeling abnormal—Dactinomycin—muscle cancer	0.00103	0.00313	CcSEcCtD
Cefepime—Anaemia—Etoposide—muscle cancer	0.00102	0.00312	CcSEcCtD
Cefepime—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00102	0.00311	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—muscle cancer	0.001	0.00305	CcSEcCtD
Cefepime—Paraesthesia—Vincristine—muscle cancer	0.001	0.00305	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000992	0.00302	CcSEcCtD
Cefepime—Leukopenia—Etoposide—muscle cancer	0.000992	0.00302	CcSEcCtD
Cefepime—Abdominal pain—Dactinomycin—muscle cancer	0.000987	0.00301	CcSEcCtD
Cefepime—Body temperature increased—Dactinomycin—muscle cancer	0.000987	0.00301	CcSEcCtD
Cefepime—Gastrointestinal disorder—Vincristine—muscle cancer	0.000963	0.00293	CcSEcCtD
Cefepime—Convulsion—Etoposide—muscle cancer	0.00096	0.00292	CcSEcCtD
Cefepime—Pain—Vincristine—muscle cancer	0.000954	0.00291	CcSEcCtD
Cefepime—Constipation—Vincristine—muscle cancer	0.000954	0.00291	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—muscle cancer	0.000943	0.00287	CcSEcCtD
Cefepime—Hypersensitivity—Dactinomycin—muscle cancer	0.00092	0.0028	CcSEcCtD
Cefepime—Gastrointestinal pain—Vincristine—muscle cancer	0.000913	0.00278	CcSEcCtD
Cefepime—Confusional state—Etoposide—muscle cancer	0.000912	0.00277	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—muscle cancer	0.000904	0.00275	CcSEcCtD
Cefepime—Anaphylactic shock—Etoposide—muscle cancer	0.000904	0.00275	CcSEcCtD
Cefepime—Infection—Etoposide—muscle cancer	0.000898	0.00273	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—muscle cancer	0.00089	0.00271	CcSEcCtD
Cefepime—Thrombocytopenia—Etoposide—muscle cancer	0.000885	0.00269	CcSEcCtD
Cefepime—Abdominal pain—Vincristine—muscle cancer	0.000882	0.00269	CcSEcCtD
Cefepime—Body temperature increased—Vincristine—muscle cancer	0.000882	0.00269	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000859	0.00262	CcSEcCtD
Cefepime—Diarrhoea—Dactinomycin—muscle cancer	0.000855	0.0026	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—muscle cancer	0.000854	0.0026	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000842	0.00256	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000841	0.00256	CcSEcCtD
Cefepime—Renal failure—Methotrexate—muscle cancer	0.000835	0.00254	CcSEcCtD
Cefepime—Hypersensitivity—Vincristine—muscle cancer	0.000822	0.0025	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—muscle cancer	0.000816	0.00249	CcSEcCtD
Cefepime—Paraesthesia—Etoposide—muscle cancer	0.000812	0.00247	CcSEcCtD
Cefepime—Dyspnoea—Etoposide—muscle cancer	0.000806	0.00245	CcSEcCtD
Cefepime—Vomiting—Dactinomycin—muscle cancer	0.000794	0.00242	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—muscle cancer	0.000793	0.00241	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—muscle cancer	0.000792	0.00241	CcSEcCtD
Cefepime—Rash—Dactinomycin—muscle cancer	0.000788	0.0024	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—muscle cancer	0.000783	0.00238	CcSEcCtD
Cefepime—Gastrointestinal disorder—Etoposide—muscle cancer	0.00078	0.00238	CcSEcCtD
Cefepime—Pain—Etoposide—muscle cancer	0.000773	0.00235	CcSEcCtD
Cefepime—Constipation—Etoposide—muscle cancer	0.000773	0.00235	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—muscle cancer	0.000771	0.00235	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—muscle cancer	0.000766	0.00233	CcSEcCtD
Cefepime—Diarrhoea—Vincristine—muscle cancer	0.000764	0.00232	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—muscle cancer	0.000762	0.00232	CcSEcCtD
Cefepime—Feeling abnormal—Etoposide—muscle cancer	0.000745	0.00227	CcSEcCtD
Cefepime—Nausea—Dactinomycin—muscle cancer	0.000742	0.00226	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—muscle cancer	0.000739	0.00225	CcSEcCtD
Cefepime—Gastrointestinal pain—Etoposide—muscle cancer	0.000739	0.00225	CcSEcCtD
Cefepime—Dizziness—Vincristine—muscle cancer	0.000738	0.00225	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000729	0.00222	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—muscle cancer	0.000723	0.0022	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—muscle cancer	0.000721	0.00219	CcSEcCtD
Cefepime—Urticaria—Etoposide—muscle cancer	0.000718	0.00219	CcSEcCtD
Cefepime—Body temperature increased—Etoposide—muscle cancer	0.000715	0.00218	CcSEcCtD
Cefepime—Abdominal pain—Etoposide—muscle cancer	0.000715	0.00218	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—muscle cancer	0.000715	0.00218	CcSEcCtD
Cefepime—Vomiting—Vincristine—muscle cancer	0.00071	0.00216	CcSEcCtD
Cefepime—Rash—Vincristine—muscle cancer	0.000704	0.00214	CcSEcCtD
Cefepime—Dermatitis—Vincristine—muscle cancer	0.000703	0.00214	CcSEcCtD
Cefepime—Headache—Vincristine—muscle cancer	0.000699	0.00213	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—muscle cancer	0.000686	0.00209	CcSEcCtD
Cefepime—Chills—Methotrexate—muscle cancer	0.000684	0.00208	CcSEcCtD
Cefepime—Hypersensitivity—Etoposide—muscle cancer	0.000666	0.00203	CcSEcCtD
Cefepime—Erythema—Methotrexate—muscle cancer	0.000664	0.00202	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—muscle cancer	0.000663	0.00202	CcSEcCtD
Cefepime—Nausea—Vincristine—muscle cancer	0.000663	0.00202	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—muscle cancer	0.00066	0.00201	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—muscle cancer	0.00065	0.00198	CcSEcCtD
Cefepime—Pruritus—Etoposide—muscle cancer	0.00064	0.00195	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—muscle cancer	0.000624	0.0019	CcSEcCtD
Cefepime—Diarrhoea—Etoposide—muscle cancer	0.000619	0.00188	CcSEcCtD
Cefepime—Anaemia—Methotrexate—muscle cancer	0.000613	0.00187	CcSEcCtD
Cefepime—Dizziness—Etoposide—muscle cancer	0.000598	0.00182	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—muscle cancer	0.000594	0.00181	CcSEcCtD
Cefepime—Chills—Doxorubicin—muscle cancer	0.000592	0.0018	CcSEcCtD
Cefepime—Convulsion—Methotrexate—muscle cancer	0.000575	0.00175	CcSEcCtD
Cefepime—Vomiting—Etoposide—muscle cancer	0.000575	0.00175	CcSEcCtD
Cefepime—Erythema—Doxorubicin—muscle cancer	0.000575	0.00175	CcSEcCtD
Cefepime—Rash—Etoposide—muscle cancer	0.00057	0.00174	CcSEcCtD
Cefepime—Dermatitis—Etoposide—muscle cancer	0.000569	0.00173	CcSEcCtD
Cefepime—Headache—Etoposide—muscle cancer	0.000566	0.00172	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—muscle cancer	0.000563	0.00171	CcSEcCtD
Cefepime—Confusional state—Methotrexate—muscle cancer	0.000546	0.00166	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—muscle cancer	0.000542	0.00165	CcSEcCtD
Cefepime—Infection—Methotrexate—muscle cancer	0.000538	0.00164	CcSEcCtD
Cefepime—Nausea—Etoposide—muscle cancer	0.000537	0.00163	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—muscle cancer	0.000531	0.00162	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—muscle cancer	0.00053	0.00161	CcSEcCtD
Cefepime—Agitation—Doxorubicin—muscle cancer	0.000528	0.00161	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—muscle cancer	0.000514	0.00157	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—muscle cancer	0.000498	0.00152	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—muscle cancer	0.000486	0.00148	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—muscle cancer	0.000483	0.00147	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—muscle cancer	0.000473	0.00144	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—muscle cancer	0.000469	0.00143	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000468	0.00142	CcSEcCtD
Cefepime—Infection—Doxorubicin—muscle cancer	0.000466	0.00142	CcSEcCtD
Cefepime—Pain—Methotrexate—muscle cancer	0.000463	0.00141	CcSEcCtD
Cefepime—Shock—Doxorubicin—muscle cancer	0.000461	0.0014	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—muscle cancer	0.000459	0.0014	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—muscle cancer	0.000446	0.00136	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—muscle cancer	0.000443	0.00135	CcSEcCtD
Cefepime—Urticaria—Methotrexate—muscle cancer	0.00043	0.00131	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—muscle cancer	0.000428	0.0013	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—muscle cancer	0.000428	0.0013	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—muscle cancer	0.000421	0.00128	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—muscle cancer	0.000418	0.00127	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000405	0.00123	CcSEcCtD
Cefepime—Pain—Doxorubicin—muscle cancer	0.000401	0.00122	CcSEcCtD
Cefepime—Constipation—Doxorubicin—muscle cancer	0.000401	0.00122	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—muscle cancer	0.000399	0.00121	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—muscle cancer	0.000386	0.00118	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000383	0.00117	CcSEcCtD
Cefepime—Pruritus—Methotrexate—muscle cancer	0.000383	0.00117	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—muscle cancer	0.000372	0.00113	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—muscle cancer	0.000371	0.00113	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—muscle cancer	0.000371	0.00113	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—muscle cancer	0.000371	0.00113	CcSEcCtD
Cefepime—Dizziness—Methotrexate—muscle cancer	0.000358	0.00109	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—muscle cancer	0.000345	0.00105	CcSEcCtD
Cefepime—Vomiting—Methotrexate—muscle cancer	0.000344	0.00105	CcSEcCtD
Cefepime—Rash—Methotrexate—muscle cancer	0.000341	0.00104	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—muscle cancer	0.000341	0.00104	CcSEcCtD
Cefepime—Headache—Methotrexate—muscle cancer	0.000339	0.00103	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—muscle cancer	0.000332	0.00101	CcSEcCtD
Cefepime—Nausea—Methotrexate—muscle cancer	0.000322	0.000979	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—muscle cancer	0.000321	0.000977	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—muscle cancer	0.00031	0.000944	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—muscle cancer	0.000298	0.000908	CcSEcCtD
Cefepime—Rash—Doxorubicin—muscle cancer	0.000296	0.0009	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—muscle cancer	0.000295	0.000899	CcSEcCtD
Cefepime—Headache—Doxorubicin—muscle cancer	0.000294	0.000894	CcSEcCtD
Cefepime—Nausea—Doxorubicin—muscle cancer	0.000279	0.000848	CcSEcCtD
